Alyssa Kneller
She currently serves as the director of content development at the Novartis Institutes for BioMedical Research.
-
Combination of two compounds shows promise in the lab
Access to HealthcareBiomedical ResearchCancerChronic IllnessDiseases -
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
Biomedical ResearchDigitalDiseasesDrug DiscoveryEmerging TechnologyNovartis Institutes for BioMedical Research -
Biomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchBiomedical Science
-
Compounds block a protein involved in many cancers by cementing it shut.
Biomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific Discoveries -
A diminutive protein prompts a closer look at DNA dark matter.
Novartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific Discoveries -
Experts call for significant changes to facilitate the discovery of new treatments.
Drug DiscoveryNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesClinical ResearchBiomedical Science -
New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.
Biomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesScientific Research -
Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.
Biomedical ResearchGene SequencingNovartis Institutes for BioMedical ResearchReimagine MedicineNext Generation SequencingGenetic Disease -
Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model
Biomedical ResearchNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesDrug Design -
Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
Cell and Gene TherapyDigitalEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchGenetic Disease -
Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
Novartis Institutes for BioMedical ResearchReimagine MedicineTargeted Therapy -
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Novartis Institutes for BioMedical ResearchPostdoc ProgramNew Scientific DiscoveriesBiomedical ScienceGenetic Disease
Pagination
- 1
- 2
- › Next page